Blood coagulation factor XIII and factor XIII deficiency

Blood Reviews

Volumn 30, Issue 6, 2016, Pages 461-475

  Dorgalaleh, Akbar ^a   Rashidpanah, Jamal ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical manifestations; Diagnosis; Factor XIII deficiency

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; CYCLOPHOSPHAMIDE; MESSENGER RNA; PREDNISONE; RITUXIMAB;

ACQUIRED FACTOR XIII DEFICIENCY; AMINO ACID SUBSTITUTION; ANGIOGENESIS; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLOT SOLUBILITY TEST; CPG ISLAND; DIAGNOSTIC TEST; FACTOR XIII ANTIGEN ASSAY; FLUOROMETRIC ASSAY; FXIII A GENE; FXIII B GENE; GENE STRUCTURE; GENETIC VARIATION; HEMOSTASIS; HUMAN; INCORPORATION ASSAY; LABORATORY DIAGNOSIS; MAJOR SURGERY; MINOR SURGERY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PHOTOMETRIC ASSAY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SPONTANEOUS ABORTION; STRUCTURE ACTIVITY RELATION; WOUND HEALING; BLOOD; BLOOD CLOTTING; CHEMISTRY; COMPLICATION; DISEASE MANAGEMENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; MUTATION; PHENOTYPE; PREGNANCY;

ABORTION, SPONTANEOUS; BLOOD COAGULATION; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; FACTOR XIII; FACTOR XIII DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; MALE; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PREGNANCY; WOUND HEALING;

EID: 84994765074     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2016.06.002     Document Type: Review

References (174)

1. [1] Dorgalaleh, A., Naderi, M., Hosseini, M.S., Alizadeh, S., Hosseini, S., Tabibian, S., et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost 41:3 (2015), 323–329.
2. [2] Muszbek, L., Yee, V.C., Hevessy, Z., Blood coagulation factor XIII: structure and function. Thromb Res 94:5 (1999), 271–305.
3. [3] Inbal, A., Dardik, R., Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair. Pathophysiol Haemost Thromb 35:1–2 (2006), 162–165.
4. [4] Muszbek, L., Bereczky, Z., Bagoly, Z., Komáromi, I., Katona, É., Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 91:3 (2011), 931–972.
5. [5] Nahrendorf, M., Hu, K., Frantz, S., Jaffer, F.A., Tung, C.-H., Hiller, K.-H., et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation 113:9 (2006), 1196–1202.
6. [6] Naderi, M., Dorgalaleh, A., Alizadeh, S., Tabibian, S., Hosseini, S., Shamsizadeh, M., et al. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol 100:5 (2014), 443–449.
7. [7] Nugent, D., Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study. Thromb Res, 130(13), 2012, S12-S14.
8. [8] Inbal, A., Oldenburg, J., Carcao, M., Rosholm, A., Tehranchi, R., Nugent, D., Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood 119:22 (2012), 5111–5117.
9. [9] Kohler, H., Ichinose, A., Seitz, R., Ariens, R., Muszbek, L., Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 9:7 (2011), 1404–1406.
10. [10] Dorgalaleh, A., Tabibian, S., Hosseini, S., Shamsizadeh, M., Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagul Fibrinolysis 27:4 (2016), 361–364.
11. [11] Pisano, J.J., Finlayson, J.S., Peyton, M.P., Chemical and enzymic detection of protein cross-links. Measurement of. epsilon.-(. gamma.-glutamyl) lysine in fibrin polymerized by Factor XIII. Biochemistry 8:3 (1969), 871–876.
12. [12] Ichinose, A., Hendrickson, L.E., Fujikawa, K., Davie, E.W., Amino acid sequence of the a subunit of human factor XIII. Biochemistry 25:22 (1986), 6900–6906.
13. [13] Dardik, R., Loscalzo, J., Inbal, A., Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 4:1 (2006), 19–25.
14. [14] Takagi, T., Doolittle, R.F., Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 13:4 (1974), 750–756.
15. [15] Greenberg, C.S., Miraglia, C.C., Rickles, F.R., Shuman, M.A., Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest, 75(5), 1985, 1463.
16. [16] Schroeder, V., Vuissoz, J., Caflisch, A., Kohler, H.P., Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thromb Haemost 97:6 (2007), 890–898.
17. [17] Hornyak, T.J., Shafer, J.A., Role of calcium ion in the generation of factor XIII activity. Biochemistry 30:25 (1991), 6175–6182.
18. [18] Handrkova, H., Schroeder, V., Kohler, H., The activation peptide of coagulation factor XIII is vital for its expression and stability. J Thromb Haemost 13:8 (2015), 1449–1458.
19. [19] Kristiansen, G.K., Andersen, M.D., Reversible activation of cellular factor XIII by calcium. J Biol Chem 286:11 (2011), 9833–9839.
20. [20] Polgar, J., Hidasi, V., Muszbek, L., Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 267 (1990), 557–560.
21. [21] Ariëns, R.A., Lai, T.-S., Weisel, J.W., Greenberg, C.S., Grant, P.J., Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:3 (2002), 743–754.
22. [22] Moaddel, M., Farrell, D.H., Daugherty, M.A., Fried, M.G., Interactions of human fibrinogens with factor XIII: roles of calcium and the γPeptide. Biochemistry 39:22 (2000), 6698–6705.
23. [23] Holbrook, J.J., Cooke, R.D., Kingston, I.B., The amino acid sequence around the reactive cysteine residue in human plasma factor XIII. Biochem J 135:4 (1973), 901–903.
24. [24] Iwata, Y., Tago, K., Kiho, T., Kogen, H., Fujioka, T., Otsuka, N., et al. Conformational analysis and docking study of potent factor XIIIa inhibitors having a cyclopropenone ring. J Mol Graph Model 18:6 (2000), 591–599.
25. [25] Tei, L., Mazooz, G., Shellef, Y., Avni, R., Vandoorne, K., Barge, A., et al. Novel MRI and fluorescent probes responsive to the factor XIII transglutaminase activity. Contrast Media Mol Imaging 5:4 (2010), 213–222.
26. [26] Souri, M., Kaetsu, H., Ichinose, A., Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry 47:33 (2008), 8656–8664.
27. [27] Souri, M., Osaki, T., Ichinose, A., The non-catalytic B subunit of coagulation factor XIII accelerates fibrin cross-linking. J Biol Chem 290:19 (2015), 12027–12039.
28. [28] Kerlin, B., Brand, B., Inbal, A., Halimeh, S., Nugent, D., Lundblad, M., et al. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. J Thromb Haemost 12:12 (2014), 2038–2043.
29. [29] Komaromi, I., Bagoly, Z., Muszbek, L., Factor XIII: novel structural and functional aspects. J Thromb Haemost 9:1 (2011), 9–20.
30. [30] Nurminskaya, M., Kaartinen, M.T., Transglutaminases in mineralized tissues. Front Biosci 11:2 (2006), 1591–1606.
31. [31] Bakker, E.N., Pistea, A., Spaan, J.A., Rolf, T., de Vries, C.J., van Rooijen, N., et al. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase possible compensation by macrophage-derived factor XIII. Circ Res 99:1 (2006), 86–92.
32. [32] Dorgalaleh, A., Naderi, M., Shamsizadeh, M., Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol 95:3 (2016), 451–455.
33. [33] Inbal, A., Muszbek, L., Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 29:2 (2003), 171–174.
34. [34] Koseki-Kuno, S., Yamakawa, M., Dickneite, G., Ichinose, A., Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 102:13 (2003), 4410–4412.
35. [35] Asahina, T., Kobayashi, T., Okada, Y., Goto, J., Terao, T., Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 21:4 (2000), 388–393.
36. [36] Suh, T.T., Holmbäck, K., Jensen, N.J., Daugherty, C.C., Small, K., Simon, D.I., et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9:16 (1995), 2020–2033.
37. [37] Inbal, A., Lubetsky, A., Krapp, T., Castel, D., Shaish, A., Dickneitte, G., et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 94:2 (2005), 432–437.
38. [38] Dickneite, G., Metzner, H.J., Kroez, M., Hein, B., Nicolay, U., The importance of factor XIII as a component of fibrin sealants. J Surg Res 107:2 (2002), 186–195.
39. [39] Kikuchi, H., Kuribayashi, F., Imajoh-Ohmi, S., Down-regulation of Fas-mediated apoptosis by plasma transglutaminase factor XIII that catalyzes fetal-specific cross-link of the Fas molecule. Biochem Biophys Res Commun 443:1 (2014), 13–17.
40. [40] Dardik, R., Solomon, A., Loscalzo, J., Eskaraev, R., Bialik, A., Goldberg, I., et al. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 23:8 (2003), 1472–1477.
41. [41] Navarrete, M., García, J., Dutzan, N., Henríquez, L., Puente, J., Carvajal, P., et al. Interferon-γ, interleukins-6 and-4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis. J Periodontol 85:5 (2014), 751–760.
42. [42] Haroonza, Hettasch, J.M., Lai, T.-S., Dewhirst, M.W., Greenberg, C.S., Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 13:13 (1999), 1787–1795.
43. [43] Paye, M., Nusgens, B., Lapiere, C., Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. Pathophysiol Haemost Thromb 19:5 (1989), 274–283.
44. [44] Wozniak, G., Noll, T., Factor XIII and wound healing. Hamostaseologie 22:1 (2002), 59–62.
45. [45] Andersson, C., Kvist, P.H., McElhinney, K., Baylis, R., Gram, L.K., Pelzer, H., et al. Factor XIII Transglutaminase supports the resolution of mucosal damage in experimental colitis. PLoS One, 10(6), 2015, e0128113.
46. [46] Ichinose, A., Davie, E.W., Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci U S A 85:16 (1988), 5829–5833.
47. [47] Biswas, A., Ivaskevicius, V., Seitz, R., Thomas, A., Oldenburg, J., An update of the mutation profile of Factor 13 A and B genes. Blood Rev 25:5 (2011), 193–204.
48. [48] Board, P., Genetic polymorphism of the B subunit of human coagulation factor XIII. Am J Hum Genet, 32(3), 1980, 348.
49. [49] Anwar, R., Gallivan, L., Edmonds, S.D., Markham, A.F., Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 93:3 (1999), 897–905.
50. [50] Attié-Castro, F.A., Zago, M.A., Lavinha, J., Elion, J., Rodriguez-Delfin, L., Guerreiro, J.F., et al. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 84:4 (2000), 601–603.
51. [51] Kangsadalampai, S., Board, P., The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:8 (1998), 2766–2770.
52. [52] Pruissen, D.M.O., Slooter, A.J., Rosendaal, F.R., van der Graaf, Y., Algra, A., Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 111:3 (2008), 1282–1286.
53. [53] Elbaz, A., Poirier, O., Canaple, S., Chédru, F., Cambien, F., Amarenco, P., The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 95:2 (2000), 586–591.
54. [54] Dossenbach-Glaninger, A., van Trotsenburg, M., Dossenbach, M., Oberkanins, C., Moritz, A., Krugluger, W., et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49:7 (2003), 1081–1086.
55. [55] Ryan, A.W., Hughes, D.A., Tang, K., Kelleher, D.P., Ryan, T., McManus, R., et al. Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus. Eur J Hum Genet 17:2 (2009), 219–227.
56. [56] Komanasin, N., Catto, A., Futers, T., Hylckama Vlieg, A., Rosendaal, F., Ariens, R., A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. J Thromb Haemost 3:11 (2005), 2487–2496.
57. [57] Mezei, Z.A., Bereczky, Z., Katona, É., Gindele, R., Balogh, E., Fiatal, S., et al. Factor XIII B subunit polymorphisms and the risk of coronary artery disease. Int J Mol Sci 16:1 (2015), 1143–1159.
58. [58] Iwata, H., Kitano, T., Umetsu, K., Yuasa, I., Yamazaki, K., Kemeks-mattes, B., et al. Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: the first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems. J Thromb Haemost 7:7 (2009), 1084–1091.
59. [59] Saha, N., Aston, C.E., Low, P.S., Kamboh, M.I., Racial and genetic determinants of plasma factor XIII activity. Genet Epidemiol 19:4 (2000), 440–455.
60. [60] Dorgalaleh, A., Kazemi, A., Zaker, F., Shamsizadeh, M., Rashidpanah, J., Mollaei, M., Laboratory Diagnosis of Factor XIII Deficiency, Routine Coagulation Tests with Quantitative and Qualitative Methods. Clin. Lab 62:4 (2016), 491–498.
61. [61] Lawrie, A., Green, L., Mackie, I., Liesner, R., Machin, S., Peyvandi, F., Factor XIII – an under diagnosed deficiency – are we using the right assays?. J Thromb Haemost 8:11 (2010), 2478–2482.
62. [62] Board, P., Coggan, M., Miloszewski, K., Identification of a point mutation in factor XIII A subunit deficiency. Blood 80:4 (1992), 937–941.
63. [63] Kangsadalampai, S., Chelvanayagam, G., Baker, R.T., Yenchitsomanus, P., Pung-amritt, P., Mahasandana, C., et al. A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function. Blood 92:2 (1998), 481–487.
64. [64] Schroeder, V., Meili, E., Cung, T., Schmutz, P., Kohler, H.P., Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thromb Haemost 95:1 (2006), 77–84.
65. [65] Anwar, R., Miloszewski, K.J., Markham, A.F., Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. Blood 91:1 (1998), 149–153.
66. [66] Trinh, C.H., Sh ElSayed, W., Eshghi, P., Miri-Moghaddam, E., Zadeh-Vakili, A., Markham, A.F., et al. Molecular analysis of sixteen unrelated factor XIIIA deficient families from south-east of Iran. Br J Hematol 140:5 (2008), 581–584.
67. [67] Ivaskevicius, V., Seitz, R., Kohler, H.P., Schroeder, V., Muszbek, L., Ariens, R.A., et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost, 97(6), 2007, 914.
68. [68] Jang, M.-A., Park, Y.S., Lee, K.-O., Kim, H.-J., Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency. Blood Coagul Fibrinolysis 26:1 (2015), 46–49.
69. [69] Vysokovsky, A., Saxena, R., Landau, M., Zivelin, A., Eskaraev, R., Rosenberg, N., et al. Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2:10 (2004), 1790–1797.
70. [70] Mikkola, H., Yee, V.C., Syrjala, M., Seitz, R., Egbring, R., Petrini, P., et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 87:1 (1996), 141–151.
71. [71] Louhichi, N., Medhaffar, M., HadjSalem, I., Mkaouar-Rebai, E., Fendri-Kriaa, N., Kanoun, H., et al. Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect. Ann Hematol 89:5 (2010), 499–504.
72. [72] Shanbhag, S., Shetty, S., Ghosh, K., Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected. Haemophilia 17:5 (2011), e843–e845.
73. [73] Castaman, G., Giacomelli, S., Ivaskevicius, V., Schroeder, V., Kohler, H., Dragani, A., et al. Molecular characterization of five Italian families with inherited severe factor XIII deficiency. Haemophilia 14:1 (2008), 96–102.
74. [74] Biswas, A., Ivaskevicius, V., Thomas, A., Varvenne, M., Brand, B., Rott, H., et al. Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Ann Hematol 93:10 (2014), 1665–1676.
75. [75] Castaman, G., Giacomelli, S., Schroeder, V., Sanna, S., Valdrè, L., Morfini, M., et al. Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency. Haemophilia 18:1 (2012), e6–e8.
76. [76] Wu, S., Wang, Z., Dong, N., Zhang, W., Bai, X., Ruan, C., A novel genetic defect in a Chinese family with inherited coagulation factor XIII deficiency. Zhonghua Xue Ye Xue Za Zhi 27:3 (2006), 145–149.
77. [77] Anwar, R., Langlois, S., The Arg703Trp missense mutation in F13A1 is a de novo event. Br J Haematol 146:1 (2009), 118–120.
78. [78] Ivaskevicius, V., Biswas, A., Bevans, C., Schroeder, V., Kohler, H.P., Rott, H., et al. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 95:6 (2010), 956–962.
79. [79] Aslam, S., Poon, M.C., Yee, V.C., Bowen, D.J., Standen, G.R., Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit. Br J Haematol 91:2 (1995), 452–457.
80. [80] Inbal, A., Yee, V., Kornbrot, N., Zivelin, A., Brenner, B., Seligsohn, U., Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families. Thromb Haemost 77:6 (1997), 1062–1067.
81. [81] Takahashi, N., Tsukamoto, H., Umeyama, H., Castaman, G., Rodeghiero, F., Ichinose, A., Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. Blood 91:8 (1998), 2830–2838.
82. [82] Anwar, R., Gallivan, L., Miloszewski, K.J., Markham, A.F., Splicing and missense mutations in the human FXIIIA gene causing FXIII deficiency: effects of these mutations on FXIIIA RNA processing and protein structure. Br J Haematol 103:2 (1998), 425–428.
83. [83] Birben, E., Öner, R., Öner, C., Gümrük, F., Altay, Ç., Gürgey, A., Mutations in coagulation factor XIII A gene in three Turkish patients: two novel mutations and a known insertion. Br J Haematol 118:1 (2002), 278–281.
84. [84] Coggan, M., Baker, R., Miloszewski, K., Woodfield, G., Board, P., Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast. Blood 85:9 (1995), 2455–2460.
85. [85] Board, P., Lososky, M., Miloszewski, K., Factor XIII: inherited and acquired deficiency. Blood Rev 7:4 (1993), 229–242.
86. [86] Kangsadalampai, S., Yenchitsomanus, P., Chelvanayagam, G., Sawasdee, N., Laosombat, V., Board, P., Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency. Eur J Haematol 65:4 (2000), 279–284.
87. [87] Ivaskevicius, V., Windyga, J., Baran, B., Schroeder, V., Junen, J., Bykowska, K., et al. Phenotype–genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia 13:5 (2007), 649–657.
88. [88] Jayandharan, G.R., Viswabandya, A., Baidya, S., Nair, S.C., George, B., Mathews, V., et al. Mutations in coagulation factor XIII A gene in eight unrelated Indians Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost 95:3 (2006), 551–556.
89. [89] Kulkarni, B.P., Nair, S.B., Vijapurkar, M., Mota, L., Shanbhag, S., Ali, S., et al. Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review. PLoS One 9:9 (2014), e1083–e1086.
90. [90] Duan, B., Wang, X., Chu, H., Hu, Y., Huang, X., Qu, B., et al. Deficiency of factor XIII gene in Chinese: 3 novel mutations. Int J Hematol 78:3 (2003), 251–255.
91. [91] Borhany, M., Handrkova, H., Cairo, A., Schroeder, V., Fatima, N., Naz, A., et al. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Haemophilia 20:4 (2014), 568–574.
92. [92] Shanbhag, S., Ghosh, K., Shetty, S., Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: identification of fourteen novel mutations. Blood Cells Mol Dis 57:6 (2016), 81–84.
93. [93] Anwar, R., Stewart, A.D., Miloszewski, K.J., Losowsky, M.S., Markham, A.F., Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 91:3 (1995), 728–735.
94. [94] Anwar, R., Gallivan, L., Trinh, C.H., Hill, F.G., Markham, A.F., Identification of a new Leu354Pro mutation responsible for factor XIII deficiency. Eur J Haematol 66:2 (2001), 133–136.
95. [95] Gomez Garcia, E., Poort, S., Stibbe, J., Sturk, A., Schaap, M., Kappers, M., et al. Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol 112:2 (2001), 513–518.
96. [96] Katona, É., Muszbek, L., Devreese, K., Kovács, K., Bereczky, Z., Jonkers, M., et al. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations. Haemophilia 20:1 (2014), 114–120.
97. [97] Birben, E., Öner, C., Öner, R., Altay, Ç., Gürgey, A., Identification of an inframe deletion and a missense mutation in the factor XIIIA gene in two Turkish patients. Eur J Haematol 71:1 (2003), 39–43.
98. [98] Anwar, R., Minford, A., Gallivan, L., Trinh, C.H., Markham, A.F., Delayed umbilical bleeding—a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 109:2 (2002), e32–e38.
99. [99] Halverstadt, A., Walsh, S., Roth, S.M., Ferrell, R.E., Hagberg, J.M., Identification of a novel mutation combination in factor XIII deficiency: genetic update to the first reported case in the United States. Int J Hematol 83:2 (2006), 144–146.
100. [100] Zheng, W., Liu, Y., He, Q., Chen, Z., Fan, X., Liu, H., Identification of Arg77Cys and Arg174stop double heterozygous mutation in a Chinese family with inherited FXIII deficiency. Zhonghua Xue Ye Xue Za Zhi 30:3 (2009), 158–161.
101. [101] Fukui, H., Yoshiya, H., Katagiri, S., Yoshioka, A., Mikami, S., Congenital factor XIII (fibrin stabilizing factor) deficiency: report of three cases. Rinsho Ketsueki 15:2 (1974), 191–200.
102. [102] Onland, W., Böing, A., Meijer, A., Schaap, M., Nieuwland, R., Haasnoot, K., et al. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family. Haemophilia 11:5 (2005), 539–547.
103. [103] Anwar, R., Gallivan, L., Miloszewski, K.J., Markham, A.F., Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene. Thromb Haemost 84:4 (2000), 591–594.
104. [104] Anwar, R., Gallivan, L., Richards, M., Khair, K., Wright, M., Minford, A., Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene. Haematologica 90:12 (2005), 1718–1720.
105. [105] Vysokovsky, A., Rosenberg, N., Dardik, R., Seligsohn, U., Inbal, A., Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins. Blood Coagul Fibrinolysis 17:2 (2006), 125–130.
106. [106] Maak, B., Kochhan, L., Heuchel, P., Jenderny, J., FXIII deficiency due to base exchange Thr 449 (ACT) → Ile (ATT) in exon 11 of the factor 13A gene. Hamostaseologie 30:3 (2010), 162–164.
107. [107] Corral, J., González-Conejero, R., Iniesta, J.A., Rivera, J., Martínez, C., Vicente, V., The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85:3 (2000), 293–297.
108. [108] Souri, M., Biswas, A., Misawa, M., Omura, H., Ichinose, A., Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines. Haemophilia 20:2 (2014), 255–262.
109. [109] Standen, G., Bowen, D.J., Factor XIII ABristol 1: detection of a nonsense mutation (Arg171 → + stop codon) in factor XIII A subunit deficiency. Br J Haematol 85:4 (1993), 769–772.
110. [110] Mikkola, H., Muszbek, L., Laiho, E., Syrjälä, M., Hämäläinen, E., Haramura, G., et al. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 89:4 (1997), 1279–1287.
111. [111] Kangsadalampai, S., Farges-Berth, A., Caglayan, S., Board, P., New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII. Thromb Haemost 76:2 (1996), 139–142.
112. [112] Kamura, T., Okamura, T., Murakawa, M., Tsuda, H., Teshima, T., Shibuya, T., et al. Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5′ end of exon III. J Clin Invest 90:2 (1992), 315–319.
113. [113] Peyvandi, F., Tagliabue, L., Menegatti, M., Karimi, M., Komáromi, I., Katona, É., et al. Phenotype–genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat 23:1 (2004), 98–102.
114. [114] Aslam, S., Bowen, D.J., Mandalaki, T., Gialeraki, R., Standen, G.R., Factor XIIIA subunit deficiency due to a homozygous 13-base pair deletion in exon 3 of the A subunit gene. Am J Hematol 53:2 (1996), 77–80.
115. [115] Otaki, M., Inaba, H., Shinozawa, K., Fujita, S., Amano, K., Fukutake, K., Characterization of a large deletion that leads to congenital factor XIII deficiency. Rinsho Byori Jpn J Clin Pathol 56:3 (2008), 187–194.
116. [116] Jiao, W., Wu, J., Ding, Q., Wang, X., Xu, X., Ding, K., et al. Identification of a novel mutation of F (13) A gene in a pedigree with factor XIII deficiency. Zhonghua Xue Ye Xue Za Zhi 28:9 (2007), 598–601.
117. [117] Khalife, H., Muwakkit, S., Al-Moussawi, H., Dabbous, I., Khoury, R., Peyvandi, F., et al. Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation. Pediatr Blood Cancer 50:1 (2008), 113–114.
118. [118] Anwar, R., Miloszewski, K.J., Factor XIII deficiency. Br J Haematol 107:3 (1999), 468–484.
119. [119] Morange, P., Trigui, N., Frere, C., Chambost, H., Pouymayou, C., Uters, M., et al. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution. Blood Coagul Fibrinolysis 20:7 (2009), 605–606.
120. [120] Aslam, S., Standen, G., Bruce, L., Gialeraki, R., Mandalaki, T., A novel insertion mutation (1286insC) in exon 9 of the factor XIII-A subunit gene. Blood Coagul Fibrinolysis 9:5 (1998), 441–444.
121. [121] Trigui, N., Frère, C., d'Ercole, C., Chambost, H., Chapuis, N., Pouymayou, C., et al. Molecular characterization of a novel mutation in the factor XIII A subunit gene associated with a severe defect and an adulthood diagnosis. Haemophilia 13:2 (2007), 221–222.
122. [122] El Mahmoudi, H., Amor, M., Gouider, E., Horchani, R., Hafsia, R., Fadhlaoui, K., et al. Small insertion (c. 869insC) within F13A gene is dominant in Tunisian patients with inherited FXIII deficiency due to ancient founder effect. Haemophilia 15:5 (2009), 1176–1179.
123. [123] Niiya, T., Osawa, H., Bando, S., Oto, Y., Tokuda, K., Takeda, N., et al. A complete deficiency of coagulation factor XIII A-subunit due to a novel compound heterozygote of Ser 413 Leu missense and an nt 389 (ins G) frameshift mutation. Br J Haematol 107:4 (1999), 772–775.
124. [124] Izumi, T., Nagaoka, U., Saito, T., Takamatsu, J., Saito, H., Ichinose, A., Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency. Thromb Haemost 79:3 (1998), 479–485.
125. [125] Anwar, R., Miloszewski, K.J., Markham, A.F., New splicing mutations in the human factor XIIIA gene, each producing multiple mutant transcripts of varying abundance. Thromb Haemost 79:6 (1998), 1151–1156.
126. [126] Ivaskevicius, V., Biswas, A., Loreth, R., Schroeder, V., Ohlenforst, S., Rott, H., et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 16:4 (2010), 675–682.
127. [127] Souri, M., Izumi, T., Higashi, Y., Girolami, A., Ichinose, A., A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain. Thromb Haemost 80:2 (1998), 211–213.
128. [128] Koseki, S., Souri, M., Koga, S., Yamakawa, M., Shichishima, T., Maruyama, Y., et al. Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood 97:9 (2001), 2667–2672.
129. [129] Hashiguchi, T., Saito, M., Morishita, E., Matsuda, T., Ichinose, A., Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood 82:1 (1993), 145–150.
130. [130] Saito, M., Asakura, H., Yoshida, T., Ito, K., Okafuji, K., Yoshida, T., et al. A familial factor XIII subunit B deficiency. Br J Haematol 74:3 (1990), 290–294.
131. [131] Girolami, A., Burul, A., Fabris, F., Betterle, C., A tentative classification of factor XIII deficiency in two groups. Acta Haematol 58:5 (1976), 318–320.
132. [132] Viswabandya, A., Baidya, S., Nair, S., Abraham, A., George, B., Mathews, V., et al. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia 18:3 (2012), e195–e200.
133. [133] Duckert, F., The fibrin stabilizing factor, factor XIII. Ann Hematol 26:3 (1973), 177–179.
134. [134] Lak, M., Peyvandi, F., Ali Sharifian, A., Karimi, K., Mannucci, P., Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 1:8 (2003), 1852–1853.
135. [135] Mahmoodi, M., Peyvandi, F., Afrasiabi, A., Ghaffarpasand, F., Karimi, M., Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 22:5 (2011), 396–401.
136. [136] Mannucci, P.M., Bleeding symptoms in heterozygous factor VIII deficiency. Haematologica, 95(9), 2010, e6.
137. [137] Fadoo, Z., Merchant, Q., Rehman, K.A., New developments in the management of congenital factor XIII deficiency. J Blood Med 4:2 (2013), 65–73.
138. [138] Kessel, R., Hu, C., Shore-Lesserson, L., Rand, J., Manwani, D., A child with acquired factor XIII deficiency: case report and literature review. Haemophilia 19:6 (2013), 814–826.
139. [139] Henriksson, P., Hedner, U., Nilsson, I., Boehm, J., Robertson, B., Lorand, L., Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant. Pediatr Res 8:9 (1974), 789–791.
140. [140] Henriksson, P., Nilsson, L., Nilsson, I., Stenberg, P., Fatal iron intoxication with multiple coagulation defects and degradation of factor VIII and factor XIII. Scand J Hematol 22:3 (1979), 235–240.
141. [141] Pohlmann-Eden, B., Peters, C., Wennberg, R., Dempfle, C., Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding. Acta Neurol Scand 108:2 (2003), 142–145.
142. [142] Henriksson, P., Hedner, U., Nilsson, I., Factor XIII (Fibrin stablizing factor) in henoch-schonleins purpura. Acta Paediatr 66:3 (1977), 273–277.
143. [143] Hanafusa, N., Kondo, Y., Suzuki, M., Nakao, A., Noiri, E., Fujita, T., Double filtration plasmapheresis can decrease factor XIII activity. Ther Apher Dial 11:3 (2007), 165–170.
144. [144] Ajzner, É., Schlammadinger, Á., Kerényi, A., Bereczky, Z., Katona, É., Haramura, G., et al. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 113:3 (2009), 723–725.
145. [145] Ichinose, A., Osaki, T., Souri, M., Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies. Haemophilia 21:5 (2015), 653–658.
146. [146] Luo, Y.Y., Zhang, G.S., Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Haemophilia 17:3 (2011), 393–398.
147. [147] Franchini, M., Frattini, F., Crestani, S., Bonfanti, C., Acquired FXIII inhibitors: a systematic review. J Thromb Thrombolysis 36:1 (2013), 109–114.
148. [148] Jennings, I., Kitchen, S., Woods, T., Preston, F., Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 1:12 (2003), 2603–2608.
149. [149] Dorgalaleh, A., Farshi, Y., Alizadeh, S., Naderi, M., Tabibian, S., Kazemi, A., et al. Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost 13:9 (2015), 1735–1736.
150. [150] Hsu, P., Zantek, N.D., Meijer, P., Hayward, C., Brody, J., Zhang, X., et al. Factor XIII assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of international proficiency testing results. Semin Thromb Hemost 40:2 (2014), 232–238.
151. [151] Kárpáti, L., Penke, B., Katona, É., Balogh, I., Vámosi, G., Muszbek, L., A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 46:12 (2000), 1946–1955.
152. [152] Song, Y., Sheng, D., Taubenfeld, S.M., Matsueda, G.R., A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Anal Biochem 223:1 (1994), 88–92.
153. [153] Kohler, H., Ariëns, R., Whitaker, P., Grant, P., A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost, 80(4), 1998, 704.
154. [154] Oertel, K., Hunfeld, A., Specker, E., Reiff, C., Seitz, R., Pasternack, R., et al. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem 367:2 (2007), 152–158.
155. [155] Yorifuji, H., Anderson, K., Lynch, G.W., Van De Water, L., McDonagh, J., B protein of factor XIII: differentiation between free B and complexed B. Blood 72:5 (1988), 1645–1650.
156. [156] Katona, É., Haramura, G., Kárpáti, L., Fachet, J., Muszbek, L., A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A 2 B 2). Thromb Haemost 83:2 (2000), 268–273.
157. [157] Katona, É., Ajzner, É., Tóth, K., Kárpáti, L., Muszbek, L., Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods 258:1 (2001), 127–135.
158. [158] Nijenhuis, A., Van Bergeijk, L., Huijgens, P., Zweegman, S., Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. Haematologica, 89(5), 2004, ECR14.
159. [159] Ghosh, S., McEvoy, P., McVerry, B., Idiopathic autoantibody that inhibits fibrin monomer polymerization. Br J Haematol 53:1 (1983), 65–72.
160. [160] Schaal-Jensen, R., Kiehr, B., Boesen, H., Krabbe, J., Sommer, C., Jacobsen, H., et al. Characterization of high molecular weight plasma protein complexes induced by clotting factor rFXIII-treatment in the cynomolgus monkey. J Thromb Haemost 5:10 (2007), 2070–2078.
161. [161] Gregory, T.F., Cooper, B., Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent), 19(3), 2006, 221.
162. [162] Miller, C., Platt, S., Rice, A., Kelly, F., Soucie, J., Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. J Thromb Haemost 10:6 (2012), 1055–1061.
163. [163] Nugent, D., Ashley, C., García-Talavera, J., Lo, L., Mehdi, A., Mangione, A., Pharmacokinetics and safety of plasma-derived factor XIII concentrate in patients with congenital factor XIII deficiency. Haemophilia 21:1 (2015), 95–101.
164. [164] Suzuki, H., Kaneda, T., Tooth extraction in two patients who had a congenital deficiency of factor XIII. J Oral Maxillofac Surg 43:3 (1985), 221–224.
165. [165] Ikkala, E., Myllylä, G., Nevanlinna, H., Transfusion therapy in factor XIII deficiency. Scand J Hematol 1:4 (1964), 308–312.
166. [166] Korte, W.F., XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 24:1 (2010), 85–93.
167. [167] Key, N.S., Negrier, C., Coagulation factor concentrates: past, present, and future. Lancet 370:9585 (2007), 439–448.
168. [168] Pernod, G., Barro, C., Arnutti, B., Blanc-Jouvan, F., Garrel, S., Kahn, P., et al. Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review. Haemophilia 9:1 (2003), 121–124.
169. [169] Gootenberg, J.E., Factor concentrates for the treatment of factor XIII deficiency. Curr Opin Hematol 5:6 (1998), 372–375.
170. [170] Janbain, M., Nugent, D.J., Powell, J.S., St-Louis, J., Frame, V.B., Leissinger, C.A., Use of factor XIII concentrate in patients with congenital FXIII deficiency undergoing surgical procedures. Transfusion 55:1 (2015), 45–50.
171. [171] Kozek-Langenecker, S.A., Afshari, A., Albaladejo, P., Santullano, C.A.A., De Robertis, E., Filipescu, D.C., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30:6 (2013), 270–382.
172. [172] Ribizzi, G., Farinini, D., Gentile, R., Rizzi, D., Serrati, C., Factor XIII deficiency and head trauma: management and therapy. Neurol Sci 36:10 (2015), 1933–1934.
173. [173] Naderi, M., Alizadeh, S., Kazemi, A., Tabibian, S., Zaker, F., Bamedi, T., Kashani Khatib, Z., Dorgalaleh, A., Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases. Hematology 20:2 (2015), 112–118.
174. [174] Sharief, L., Kadir, R., Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia 19:6 (2013), e349–e357.